Echo IQ Limited (ASX:EIQ)

Market Cap	404.82M +154.8%
Revenue (ttm)	90.91K -30.0%
Net Income	-15.71M
EPS	-0.03
Shares Out	658.24M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,319,633
Average Volume	2,858,711
Open	0.6400
Previous Close	0.6150
Day's Range	0.6400 - 0.7550
52-Week Range	0.1650 - 0.7600
Beta	0.72
RSI	61.92
Earnings Date	Feb 25, 2026

About Echo IQ

Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Claremont, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• CEO: Dustin Haines
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EIQ

Financial Performance

In fiscal year 2025, Echo IQ's revenue was 101,409, an increase of 127.89% compared to the previous year's 44,500. Losses were -13.26 million, 145.2% more than in 2024.